EUVIMEDEUVIMED entdecken
Crossref

Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts

Yohei Asano, Qinghong Han, Shukuan Li, Kohei Mizuta, Byung Mo Kang, Jin Soo Kim, Yuta Miyashi, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi und 5 weitere

Anticancer Research · 2025

DOI: 10.21873/anticanres.17828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Yohei Asano und 16 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Ivermectin, Chloroquine, Carbon-Sulfur Lyases. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsIvermectinChloroquineCarbon-Sulfur LyasesFibroblastsAntineoplastic Combined Chemotherapy ProtocolsHumansCell Line, TumorRecombinant ProteinsDrug SynergismCell SurvivalAntiparasitic Agents

Stichwörter der Autor:innen

Hoffman effectRecombinant methioninase (rMETase)chloroquinecombination treatmentivermectinmethionine addictionnormal fibroblastspancreatic cancersynergy

Substanzen

L-methionine gamma-lyaseIvermectinChloroquineCarbon-Sulfur LyasesRecombinant ProteinsAntiparasitic Agents

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Asano, Y., Han, Q., Li, S., Mizuta, K., Kang, B. M., Kim, J. S., Miyashi, Y., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Morinaga, S., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2025). Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts. Anticancer Research. https://doi.org/10.21873/anticanres.17828

Vancouver

Asano Y, Han Q, Li S, Mizuta K, Kang BM, Kim JS, et al. Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts. Anticancer Research. 2025. doi:10.21873/anticanres.17828

BibTeX
@article{Asano2025,
  author = {Asano, Yohei and Han, Qinghong and Li, Shukuan and Mizuta, Kohei and Kang, Byung Mo and Kim, Jin Soo and Miyashi, Yuta and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Morinaga, Sei and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal Fibroblasts},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17828}
}
Kostenlos starten →